4.3 Article

Sphingosine kinase 1 and 2 regulate the capacity of mesangial cells to resist apoptotic stimuli in an opposing manner

Journal

BIOLOGICAL CHEMISTRY
Volume 389, Issue 11, Pages 1399-1407

Publisher

WALTER DE GRUYTER GMBH
DOI: 10.1515/BC.2008.160

Keywords

apoptosis; ceramide; mesangial cells; sphingosine-1-phosphate; sphingosine kinase knockout mice

Funding

  1. Swiss National Foundation [3100A0-111806]
  2. German Research Foundation [FOG784, GRK757/2, GRK1172, HU842/4-1, PF361/6-1, EXC147]
  3. Norwegian Research Council and Avexxin AS
  4. European Community [FP6: LSHM-CT-2004-005033]
  5. Wilhelm Sander-Foundation
  6. Novartis Foundation
  7. Hochschulstiftung der Universitat Bern

Ask authors/readers for more resources

Sphingosine kinases (SKs) are key enzymes regulating the production of sphingosine-1-phosphate (S1P), which determines important cell responses including cell growth and death. Here we show that renal mesangial cells isolated from wild-type, SK-1(-/-),and SK-2(-/-) mice show a differential response to apoptotic stimuli. Wildtype mesangial cells responded to staurosporine with increased DNA fragmentation and caspase-3 processing, which was enhanced in SK-1(-/-) cells. In contrast, SK-2(-/-) cells were highly resistant to staurosporine-induced apoptosis. Furthermore, the basal phosphorylation and activity of the anti-apoptotic protein kinase B (PKB) and of its substrate Bad were decreased in SK-1(-/-) but not in SK-2(-/-) cells. Upon staurosporine treatment, phosphorylation of PKB and Bad decreased in wild-type and SK-1(-/-) cells, but remained high in SK-2(-/-) cells. In addition, the anti-apoptotic Bcl-X-L was significantly upregulated in SK-2(-/-) cells, which may further contribute to the protective state of these cells. In summary, our data show that SK-1 and SK-2 have opposite effects on the capacity of mesangial cells to resist apoptotic stimuli. This is due to differential modulation of the PKB/Bad pathway and of Bcl-X-L expression. Thus, subtype-selective targeting of SKs will be critical when considering these enzymes as therapeutic targets for the treatment of inflammation or cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available